Cytek Biosciences
Company Details
Linkedin ID:
cytek-biosciences
Website:
Employees number:
442
Number of followers:
32,301
NAICS:
541714
Industry Type:
Homepage:
cytekbio.com
IP Addresses:
0
Company ID:
CYT_2989721
Scan Status:
In-progress
Cytek Biosciences Company CyberSecurity Posture
cytekbio.com
Cytek® Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world. Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time. At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before. As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.
Cytek Biosciences A.I CyberSecurity Scoring
Cytek Biosciences Risk Score (AI oriented)Between 650 and 699
Cytek Biosciences
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Cytek Biosciences Global Score (TPRM)XXXX
Cytek Biosciences
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Cytek Biosciences Company CyberSecurity News & History
Past Incidents
1
Attack Types
1
Cytek Biosciences and Inc.: Cytek Biosciences Data Breach Exposes Social Security Numbers
Breach
Rankiteo Explanation
Attack with significant impact with customers data leaks
Description: **Cytek Biosciences Discloses Data Breach Exposing Sensitive Consumer and Employee Information** On December 22, 2025, Cytek Biosciences, a provider of flow cytometry equipment and solutions, reported a data breach that compromised a broad range of sensitive information. The incident was disclosed to the Massachusetts Attorney General, revealing that at least eight state residents were affected, though the full nationwide impact remains undisclosed. The breach exposed personally identifiable information (PII), including names, contact details, dates of birth, Social Security numbers, driver’s license and government-issued ID numbers, citizenship status, signatures, and financial account data. Additionally, protected health information (PHI), such as medical records, was accessed, along with Cytek employee account credentials. In response, Cytek is offering affected individuals 24 months of complimentary identity protection and credit monitoring through Experian IdentityWorks, which includes daily credit report monitoring, identity restoration support, and up to $1 million in identity theft insurance. Enrollment is available until April 30, 2026, without requiring a credit card. The company has also established a dedicated support line (833-918-1243) for inquiries, operating Monday through Friday from 8 a.m. to 8 p.m. Central Time. Given the exposure of highly sensitive data, including Social Security numbers and health records, affected individuals may consider additional protective measures, such as credit freezes or fraud alerts. The official notice provides guidance on these steps and contact details for major credit bureaus.
Cytek Biosciences Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Cytek Biosciences
Incidents vs Biotechnology Research Industry Average (This Year)
Cytek Biosciences has 40.85% more incidents than the average of same-industry companies with at least one recorded incident.
Incidents vs All-Companies Average (This Year)
Cytek Biosciences has 28.21% more incidents than the average of all companies with at least one recorded incident.
Incident Types Cytek Biosciences vs Biotechnology Research Industry Avg (This Year)
Cytek Biosciences reported 1 incidents this year: 0 cyber attacks, 0 ransomware, 0 vulnerabilities, 1 data breaches, compared to industry peers with at least 1 incident.
Incident History — Cytek Biosciences (X = Date, Y = Severity)
Cytek Biosciences cyber incidents detection timeline including parent company and subsidiaries
Cytek Biosciences Company Subsidiaries
Cytek® Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world. Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time. At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before. As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.
Loading...
Cytek Biosciences Similar Companies
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
.png)
Cytek Biosciences CyberSecurity News
November 17, 2025 08:00 AM
Cytek Biosciences (CTKB): Evaluating Valuation After TIME’s 2026 Growth Leaders Recognition and Recurring Revenue Momentum
Cytek Biosciences (CTKB) has caught investor attention following its inclusion on TIME's 2026 America's Growth Leaders list.
November 12, 2025 08:00 AM
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
America's Growth Leaders Cytek Biosciences has been recognized by TIME as one of America's Growth Leaders of 2026.
November 05, 2025 08:00 AM
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -200.00% and +1.70%, respectively, for the quarter ended September 2025...
November 04, 2025 08:00 AM
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2025 Earnings
This article first appeared on GuruFocus. Cytek Biosciences Inc (NASDAQ:CTKB) is set to release its Q3 2025 earnings on Nov 5, 2025.
October 15, 2025 07:00 AM
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
Cytek European Facility Cytek's new facility in Amsterdam, The Netherlands, expands the company's capacity to meet the growing demand for...
July 30, 2025 07:00 AM
Cytek Biosciences And 2 Other Penny Stocks Worth Watching
Over the last 7 days, the market has remained flat, but it is up 17% over the past year with earnings forecasted to grow by 15% annually.
July 02, 2025 07:00 AM
Research device company to relocate local office to Bellevue
Cytek Biosciences Inc. (Nasdaq: CTKB) is moving its local office from Seattle to Bellevue at Corporate Campus East III.
June 02, 2025 07:00 AM
Cytek Biosciences Leads Our Top 3 Penny Stock Selections
Cytek Biosciences, with a market cap of US$350.85 million, is navigating the penny stock landscape by leveraging its innovative cell analysis solutions.
June 07, 2017 07:00 AM
Cytek Biosciences Debuts New Advanced Flow Cytometry System
More colors, greater flexibility, higher sensitivity, better affordability. Cytek Biosciences Inc. today announced the launch of its new...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Cytek Biosciences CyberSecurity History Information
Official Website of Cytek Biosciences
The official website of Cytek Biosciences is https://cytekbio.com/.
Cytek Biosciences’s AI-Generated Cybersecurity Score
According to Rankiteo, Cytek Biosciences’s AI-generated cybersecurity score is 690, reflecting their Weak security posture.
How many security badges does Cytek Biosciences’ have ?
According to Rankiteo, Cytek Biosciences currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Cytek Biosciences have SOC 2 Type 1 certification ?
According to Rankiteo, Cytek Biosciences is not certified under SOC 2 Type 1.
Does Cytek Biosciences have SOC 2 Type 2 certification ?
According to Rankiteo, Cytek Biosciences does not hold a SOC 2 Type 2 certification.
Does Cytek Biosciences comply with GDPR ?
According to Rankiteo, Cytek Biosciences is not listed as GDPR compliant.
Does Cytek Biosciences have PCI DSS certification ?
According to Rankiteo, Cytek Biosciences does not currently maintain PCI DSS compliance.
Does Cytek Biosciences comply with HIPAA ?
According to Rankiteo, Cytek Biosciences is not compliant with HIPAA regulations.
Does Cytek Biosciences have ISO 27001 certification ?
According to Rankiteo,Cytek Biosciences is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Cytek Biosciences
Cytek Biosciences operates primarily in the Biotechnology Research industry.
Number of Employees at Cytek Biosciences
Cytek Biosciences employs approximately 442 people worldwide.
Subsidiaries Owned by Cytek Biosciences
Cytek Biosciences presently has no subsidiaries across any sectors.
Cytek Biosciences’s LinkedIn Followers
Cytek Biosciences’s official LinkedIn profile has approximately 32,301 followers.
NAICS Classification of Cytek Biosciences
Cytek Biosciences is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Cytek Biosciences’s Presence on Crunchbase
Yes, Cytek Biosciences has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/cytek.
Cytek Biosciences’s Presence on LinkedIn
Yes, Cytek Biosciences maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/cytek-biosciences.
Cybersecurity Incidents Involving Cytek Biosciences
As of December 23, 2025, Rankiteo reports that Cytek Biosciences has experienced 1 cybersecurity incidents.
Number of Peer and Competitor Companies
Cytek Biosciences has an estimated 4,517 peer or competitor companies worldwide.
What types of cybersecurity incidents have occurred at Cytek Biosciences ?
Incident Types: The types of cybersecurity incidents that have occurred include Breach.
How does Cytek Biosciences detect and respond to cybersecurity incidents ?
Detection and Response: The company detects and responds to cybersecurity incidents through an third party assistance with experian identityworks (identity protection and credit monitoring services), and communication strategy with dedicated toll-free response line (833-918-1243), official notice with credit bureau instructions..
Incident Details
Can you provide details on each incident ?
Title: Cytek Biosciences Data Breach
Description: Cytek Biosciences, Inc. disclosed a data breach that exposed sensitive consumer information, including personally identifiable information (PII) and protected health information (PHI).
Date Publicly Disclosed: 2025-12-22
Type: Data Breach
What are the most common types of attacks the company has faced ?
Common Attack Types: The most common types of attacks the company has faced is Breach.
Impact of the Incidents
What was the impact of each incident ?
Incident : Data Breach CYT1766447891
Data Compromised: Personally identifiable information (PII) and protected health information (PHI)
Identity Theft Risk: High
Payment Information Risk: High
What types of data are most commonly compromised in incidents ?
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Personally Identifiable Information (Pii), Protected Health Information (Phi) and .
Which entities were affected by each incident ?
Incident : Data Breach CYT1766447891
Entity Name: Cytek Biosciences, Inc.
Entity Type: Corporation
Industry: Biotechnology / Flow Cytometry Equipment and Solutions
Customers Affected: At least 8 Massachusetts residents (nationwide total undisclosed)
Response to the Incidents
What measures were taken in response to each incident ?
Incident : Data Breach CYT1766447891
Third Party Assistance: Experian IdentityWorks (identity protection and credit monitoring services)
Communication Strategy: Dedicated toll-free response line (833-918-1243), official notice with credit bureau instructions
How does the company involve third-party assistance in incident response ?
Third-Party Assistance: The company involves third-party assistance in incident response through Experian IdentityWorks (identity protection and credit monitoring services).
Data Breach Information
What type of data was compromised in each breach ?
Incident : Data Breach CYT1766447891
Type of Data Compromised: Personally identifiable information (pii), Protected health information (phi)
Sensitivity of Data: High
Personally Identifiable Information: NamesContact information (postal address, email address, phone number)Dates of birthSocial Security numbersDriver’s license numbersGovernment-issued ID numbersCitizenship statusSignaturesFinancial account and compensation informationEmployee account usernames and passwords
Regulatory Compliance
Were there any regulatory violations and fines imposed for each incident ?
Incident : Data Breach CYT1766447891
Regulatory Notifications: Disclosure to Massachusetts Attorney General
Lessons Learned and Recommendations
What recommendations were made to prevent future incidents ?
Incident : Data Breach CYT1766447891
Recommendations: Enroll in complimentary identity protection and credit monitoring services, Place a security freeze or fraud alert on credit files, Regularly review account statements and credit reports for suspicious activityEnroll in complimentary identity protection and credit monitoring services, Place a security freeze or fraud alert on credit files, Regularly review account statements and credit reports for suspicious activityEnroll in complimentary identity protection and credit monitoring services, Place a security freeze or fraud alert on credit files, Regularly review account statements and credit reports for suspicious activity
References
Where can I find more information about each incident ?
Incident : Data Breach CYT1766447891
Source: Massachusetts Attorney General
Where can stakeholders find additional resources on cybersecurity best practices ?
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: Massachusetts Attorney General.
Investigation Status
How does the company communicate the status of incident investigations to stakeholders ?
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through Dedicated toll-free response line (833-918-1243) and official notice with credit bureau instructions.
Stakeholder and Customer Advisories
Were there any advisories issued to stakeholders or customers for each incident ?
Incident : Data Breach CYT1766447891
Customer Advisories: Affected individuals encouraged to enroll in identity protection services and monitor accounts
What advisories does the company provide to stakeholders and customers following an incident ?
Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: was Affected individuals encouraged to enroll in identity protection services and monitor accounts.
Post-Incident Analysis
What is the company's process for conducting post-incident analysis ?
Post-Incident Analysis Process: The company's process for conducting post-incident analysis is described as Experian IdentityWorks (identity protection and credit monitoring services).
Additional Questions
Incident Details
What was the most recent incident publicly disclosed ?
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2025-12-22.
Impact of the Incidents
What was the most significant data compromised in an incident ?
Most Significant Data Compromised: The most significant data compromised in an incident was Personally identifiable information (PII) and protected health information (PHI).
Response to the Incidents
What third-party assistance was involved in the most recent incident ?
Third-Party Assistance in Most Recent Incident: The third-party assistance involved in the most recent incident was Experian IdentityWorks (identity protection and credit monitoring services).
Data Breach Information
What was the most sensitive data compromised in a breach ?
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was Personally identifiable information (PII) and protected health information (PHI).
Lessons Learned and Recommendations
What was the most significant recommendation implemented to improve cybersecurity ?
Most Significant Recommendation Implemented: The most significant recommendation implemented to improve cybersecurity was Enroll in complimentary identity protection and credit monitoring services, Place a security freeze or fraud alert on credit files and Regularly review account statements and credit reports for suspicious activity.
References
What is the most recent source of information about an incident ?
Most Recent Source: The most recent source of information about an incident is Massachusetts Attorney General.
Stakeholder and Customer Advisories
What was the most recent customer advisory issued ?
Most Recent Customer Advisory: The most recent customer advisory issued was an Affected individuals encouraged to enroll in identity protection services and monitor accounts.
.png)
Latest Global CVEs (Not Company-Specific)
Description
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md#reproduce
- https://vuldb.com/?ctiid.337689
- https://vuldb.com/?id.337689
- https://vuldb.com/?submit.719154
- https://www.tenda.com.cn/
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=cytek-biosciences' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
